Onconano Medicine: Funding, Investors & Team (Sep 2026)
OncoNano Medicine is a biotech company that develops nanotechnology-enabled fluorescent probes to help cancer surgeons visualize tumors during surgery, allowing them to excise tumors more precisely. The fluorescent sensor targets the different pH signals, thus making them glow so they are easier to distinguish from normal tissue. OncoNano Medicine is a UTSW spinoff company based in Dallas, Texas.
Onconano Medicine has raised $50.0M across 1 funding round on record, the most recent an undisclosed round of $50.0M announced in Jun 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Onconano Medicine Company Profile and Key Stats
Latest funding round on record: Jun 2021.
Onconano Medicine Funding Rounds
Onconano Medicine Founders and Leadership Team
No contact details are on record for this team yet.
Onconano Medicine Funding Compared to Other Biotechnology Startups
Onconano Medicine's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Onconano Medicine in Biotechnology and Southlake
Companies Similar to Onconano Medicine
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Onconano Medicine Funding FAQs
What does Onconano Medicine do?
OncoNano Medicine is a biotech company that develops nanotechnology-enabled fluorescent probes to help cancer surgeons visualize tumors during surgery, allowing them to excise tumors more precisely. The fluorescent sensor targets the different pH signals, thus making them glow so they are easier to distinguish from normal tissue. OncoNano Medicine is a UTSW spinoff company based in Dallas, Texas.
How much funding has Onconano Medicine raised?
Onconano Medicine has raised $50.0M across 1 round on record. The most recent is an undisclosed round of $50.0M announced in Jun 2021.
When did Onconano Medicine last raise funding?
Onconano Medicine's most recent funding round on record is an undisclosed round of $50.0M, announced in Jun 2021.
Who is the CEO of Onconano Medicine?
Marty Driscoll is listed as CEO at Onconano Medicine.
Where is Onconano Medicine headquartered?
Onconano Medicine is based in Southlake, Texas, United States.
How many employees does Onconano Medicine have?
Onconano Medicine is in the 11-50 employee band.
How does Onconano Medicine's funding compare to other Biotechnology startups?
Onconano Medicine's latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Onconano Medicine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Onconano Medicine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.